Figure 2.
Figure 2. Cell-surface expression of WT and mutated CXCR3 receptors on HEK 293 cells. WT and mutant CXCR3 cell-surface expression on stable transfected HEK 293 cell clones was tested by immunostaining with anti-CXCR3 specific antibodies and analyzed by FACS (black line). Immunostaining with IgG1 isotype control antibodies is in gray line. (A) WT CXCR3. (B) 349stopΔ20 C-tail truncated. (C) 332stopΔ37 C-tail truncated. (D) 332-334L→A C-tail mutations. (E) S245 to A 3i loop mutation. (F) Double-mutant of 332stopΔ37 C-tail truncated and S245 to A 3i loop mutation. (G) HEK 293 cells. Counts indicate relative cell number. A representative histogram of at least 3 experiments performed is presented. (H) Binding of biotinylated I-TAC (mean florescence intensity [MFI]) at different concentrations (nM) to 293 cells expressing the different mutated or truncated CXCR3.

Cell-surface expression of WT and mutated CXCR3 receptors on HEK 293 cells. WT and mutant CXCR3 cell-surface expression on stable transfected HEK 293 cell clones was tested by immunostaining with anti-CXCR3 specific antibodies and analyzed by FACS (black line). Immunostaining with IgG1 isotype control antibodies is in gray line. (A) WT CXCR3. (B) 349stopΔ20 C-tail truncated. (C) 332stopΔ37 C-tail truncated. (D) 332-334L→A C-tail mutations. (E) S245 to A 3i loop mutation. (F) Double-mutant of 332stopΔ37 C-tail truncated and S245 to A 3i loop mutation. (G) HEK 293 cells. Counts indicate relative cell number. A representative histogram of at least 3 experiments performed is presented. (H) Binding of biotinylated I-TAC (mean florescence intensity [MFI]) at different concentrations (nM) to 293 cells expressing the different mutated or truncated CXCR3.

Close Modal

or Create an Account

Close Modal
Close Modal